MARKSANS vs INDORAMA: Stock Comparison
Head-to-head financial and trading comparison between Marksans Pharma Limited (MARKSANS) and Indo Rama Synthetics (India) Limited (INDORAMA) in the Cross-Sector Peers sector.
MARKSANS
NSE: MARKSANSINDORAMA
NSE: INDORAMAKey Metrics Comparison Table
| Metric | MARKSANS | INDORAMA | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹309.10 | ₹92.39 | — |
| 1-Year Price Return | +74.73% | +140.29% | INDORAMA (65.56% higher) |
| 52-Week High | ₹347.60 | ₹106.55 | — |
| 52-Week Low | ₹176.77 | ₹35.16 | — |
| 30-Day Annualized Volatility | 42.37% | 82.26% | MARKSANS (Steadier) |
| 30-Day Average Daily Volume | 2,394,723 | 2,295,337 | MARKSANS (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between MARKSANS and INDORAMA, which stock gave better returns over the last year?
INDORAMA has outperformed MARKSANS over the past 12 months with a gain of 140.29% compared to 74.73%.
Which stock is less volatile: MARKSANS or INDORAMA?
MARKSANS demonstrated lower price volatility (42.37% annualized) compared to INDORAMA (82.26%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of MARKSANS vs INDORAMA?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are MARKSANS and INDORAMA direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.